Claudia Wilson
Hematology & Oncology · Brooklyn, NYNPI 1205888120
Payments from drug & device makers
Across 89 payments — averaging $22.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$307
- Johnson & Johnson$291
- Regeneron Healthcare Solutions, Inc.$184
- Sanofi$154
- Recordati_rare_diseases_inc.$131
- Novartis$108
- plus $824 from 20 others
What the payments were for
- Food & beverage$2,000100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | 24 | $307 |
| Johnson & Johnson(2 entities) | 12 | $291 |
| Regeneron Healthcare Solutions, Inc. | 5 | $184 |
| Sanofi | 5 | $154 |
| Recordati_rare_diseases_inc. | 5 | $131 |
| Novartis | 4 | $108 |
| Pfizer | 3 | $85 |
| Incyte Corporation | 3 | $78 |
| Taiho Oncology, Inc. | 3 | $69 |
| AstraZeneca(2 entities) | 2 | $59 |
| Bristol Myers Squibb | 2 | $50 |
| Array Biopharma Inc | 3 | $48 |
| Global Blood Therapeutics, Inc. | 2 | $47 |
| Bayer | 2 | $46 |
| Avanir Pharmaceuticals, Inc. | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Jazz Pharmaceuticals Inc. | 1 | $36 |
| Karyopharm Therapeutics Inc. | 1 | $34 |
| Merck | 1 | $28 |
| Blueprint Medicines Corporation | 1 | $27 |
| Sobi, Inc | 1 | $26 |
| CMP Pharma, Inc. | 1 | $24 |
| Stemline Therapeutics Inc. | 1 | $24 |
| Agios Pharmaceuticals, Inc. | 1 | $23 |
| Kyowa Kirin, Inc. | 1 | $21 |
| KCI USA, Inc. | 1 | $18 |
How this compares
$2,000 in reported general payments places this provider in the 40th percentile of 967 hematology & oncology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxyurea | 12 | $461 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Brooklyn
- Vicky MakkerNew York$27.1M
- Alison MoskowitzNew York$22.7M
- Ajai ChariNew York$22.4M
- Yelena JanjigianNew York$16.9M
- Alexander LesokhinNew York$11.9M
- John MascarenhasNew York$11.8M
- Maria PalombaNew York$11.6M
- Richard ZunigaBabylon$10.9M
- Scott TagawaNew York$10.3M
- Mohammad Abdul HayNew York$9.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.